Dechert Advises Affluent Medical on Euronext Paris IPO
June 14, 2021
Dechert, a global law firm with a leading life sciences practice, advised Affluent Medical, a French medtech company specialising in urology and cardiology, in connection with its IPO on the Euronext Paris regulated market.
Affluent Medical has completed a €25 million capital increase and reached a market capitalisation of €156 million on the day of its listing. These funds will enable Affluent Medical to accelerate the development of its product portfolio.
The Dechert team advising Affluent Medical on the following aspects included:
- Corporate/capital markets: partner Alain Decombe, special counsel Sophie Lafay and associate Benhouda Derradji
- Tax structuring: partner Sabina Comis and associates Etienne Bimbeau and Pierre-Emmanuel Floc’h
- IP: national partner Marie Fillon
About Dechert
Dechert is a leading global law firm with 24 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.
Related Professionals
